Home NDC 17856-2170 Acyclovir suspension
Product NDC 17856-2170
11-digit product format 178562170
Labeler code 17856
Product ID 17856-2170_5105272f-cff9-8898-e063-6394a90aabb5
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Acyclovir
Dosage form SUSPENSION
Route ORAL
Labeler Atlantic Biologicals Corp.
Application ANDA217393
Marketing category ANDA
Marketing start 2023-03-09
Substance ACYCLOVIR
Active strength 200 mg/5mL
Pharmacologic classes DNA Polymerase Inhibitors [MoA], Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC], Nucleoside Analog [EXT]
NDC exclude flag No
Listing certified through 2027-12-31
Current FDA listing Yes Additional Listing Data#
Finished product Yes
Brand name base Acyclovir suspension
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength ACYCLOVIR 200 mg/5mL
Harmonized Identifiers# Field, Values table Field Values Unii X4HES1O11F Rxcui 307730
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 17856-2170-1 Acyclovir suspension 72 in 1 CASE SUSPENSION 72 1 17856-2170-1 Acyclovir suspension 5 mL in 1 CUP, UNIT-DOSE SUSPENSION 5 1 17856-2170-2 Acyclovir suspension 10 mL in 1 CUP, UNIT-DOSE SUSPENSION 10 1 17856-2170-2 Acyclovir suspension 72 in 1 CASE SUSPENSION 72 1
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Sample Exclude flag Status 17856-2170-1 17856217001 72 CUP, UNIT-DOSE in 1 CASE (17856-2170-1) / 5 mL in 1 CUP, UNIT-DOSE 2026-05-04 No No Historical 17856-2170-2 17856217002 72 CUP, UNIT-DOSE in 1 CASE (17856-2170-2) / 10 mL in 1 CUP, UNIT-DOSE 2026-05-04 No No Historical